reviewNew England Journal of MedicineDec 28, 2016Closed access

Myasthenia Gravis

NENils Erik Gilhus

Haukeland University Hospital

PubMed
Indexed incrossrefpubmed

Abstract

Myasthenia gravis is an autoimmune disease associated with several autoantibodies that attack the neuromuscular junction. Some cases are associated with thymoma. The hallmark of management is individualized immunosuppressive therapy.

Citation impact

1,004
total citations
FWCI
37.15
Percentile
100%
References
75
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Medicine
  • Myasthenia gravis
  • Dermatology
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.